These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4763514)

  • 1. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic unreactivity in bladder cancer patients.
    Olsson CA; Rao CN; Menzoian JO; Byrd WE
    J Urol; 1972 Apr; 107(4):607-9. PubMed ID: 5014367
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological status of patients with bladder cancers (transitional cell tumours).
    Frantz P; Khoury S; Kuss R
    Prog Clin Biol Res; 1984; 162A():201-8. PubMed ID: 6385023
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
    Morales A; Ottenhof P; Elliott M
    Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo skin test in carcinoma bladder.
    Gupta NP; Rajagopal V; Malaviya AN; Singh SM
    Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):163-5. PubMed ID: 6545227
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunodeficiency in Hodgkin disease.
    Eltringham JR; Kaplan HS
    Birth Defects Orig Artic Ser; 1975; 11(1):278-88. PubMed ID: 1148383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological responsiveness in patients with bladder cancer.
    Fahey JL; Brosman S; Dorey F
    Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
    Allard P; Fradet Y; Têtu B; Bernard P
    Clin Cancer Res; 1995 Oct; 1(10):1195-202. PubMed ID: 9815912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in uremia.
    Boulton-Jones JM; Vick R; Cameron JS; Black PJ
    Clin Nephrol; 1973; 1(6):351-60. PubMed ID: 4799080
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed skin reactivity to mumps antigen].
    Orriols R; Morell F; de Gracia X; Sanz R; Muñiz R; Joan-Miquel L
    Med Clin (Barc); 1983 Jun; 81(1):14-6. PubMed ID: 6888053
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors.
    Kronman BS; Shapiro HM; Localio SA
    Dis Colon Rectum; 1972; 15(2):106-10. PubMed ID: 5026786
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy.
    Van Epps DE; Palmer DL; Williams RC
    J Immunol; 1974 Jul; 113(1):189-200. PubMed ID: 4832308
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity to tuberculin and other antigens in a hospital population.
    Walls RS
    S Afr Med J; 1974 Oct; 48(49):2073-6. PubMed ID: 4609390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.